What's up in

Interviews & Opinions

Pharma Now
QnA

4 AM Discipline & Pharma Innovation: How Dr. Tathagata Dutta Leads by Example

FT - Dr. Tathagata Dutta | May 27, 2025 |

Pharma Now
Pharma Myth Busters

Women in Chemistry: Dr. Helen Pain on Breaking Barriers at the Royal Society of Chemistry

FT - Dr. Helen Pain | April 16, 2025 |

Pharma Now
QnA

The Future of Pharmacy: Mentorship from a Triple Licensed Pharmacist

FT - Mr. Kevin Ben Laurence | April 4, 2025 |

Pharma Now
QnA

Hear Out From the Best: How Namita Manages 7,500 Employees at Alembic Pharmaceuticals

FT - Ms. Namita Patwari | February 24, 2025 |

Pharma Now
QnA

Satish Kumar’s Promise: Grooming India’s Next Pharma Leaders

FT - Mr. Satish Kumar Vemavarapu | February 10, 2025 |

Ad
Advertisement

TRENDING

Most Viewed Interviews

Pharma Now

Marathons, Medicines, and Mastery: Elisabeth Stampa’s Blueprint for Leadership

FT - Elisabeth Stampa

Pharma Now

Retired at 47: Mr. Raghavendra’s Journey in Developing his Interest into Investing in Startups

FT - Mr. Raghavendra Goud

Ad
Advertisement
Pharma Now
QnA

The Science of GMP: Dr. Kamal Dua on Pharma & Compliance

FT - Dr. Kamal Dua | February 3, 2025 |

Dr. Kamal Dua discusses his transition from the pharma industry in India to academia at UTS, Austral...

Pharma Now
QnA

Work-Life Balance is for the Lazy? Dr. Sinha's Bold Take!

FT - Dr. Shubhadeep Sinha | January 31, 2025 |

Dr. Sinha shares insights on team building, lifelong learning, AI in clinical trials, and why work-l...

Pharma Now
QnA

Dr. Ravi Ananthula on Leaving Dr. Reddy’s to Transform Pharma

FT - Dr. Ravi Ananthula | January 20, 2025 |

Dr. Ravi Ananthula shares his inspiring journey, innovations in his software, and vision for India's...

Pharma Now
QnA

Pushpavalli Krishnamurthy: Elevating Pharmacopoeia Standards at Ingredion

FT - Ms. Pushpavalli Krishnamurthy | January 9, 2025 |

Exclusive insights from Ms. Pushpavalli Krishnamurthy on excipient regulations, global standards, an...

Ad
Advertisement

TRENDING

Most Viewed Interviews

Pharma Now

Marathons, Medicines, and Mastery: Elisabeth Stampa’s Blueprint for Leadership

FT - Elisabeth Stampa

Pharma Now

Retired at 47: Mr. Raghavendra’s Journey in Developing his Interest into Investing in Startups

FT - Mr. Raghavendra Goud

Pharma Shorts

Ad
Advertisement
News Letter

Subscribe to our Newsletter!

Be the first to get exclusive offers and the latest news